{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T05:13:24Z","timestamp":1777094004063,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T00:00:00Z","timestamp":1507075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/pr.2017.143","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T16:01:29Z","timestamp":1497369689000},"page":"142-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Polymorphisms in urea cycle enzyme genes are associated with persistent pulmonary hypertension of the newborn"],"prefix":"10.1038","volume":"83","author":[{"given":"Dinushan C","family":"Kaluarachchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin J","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey C","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M","family":"Dagle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelli K","family":"Ryckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,4]]},"reference":[{"key":"BFpr2017143_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1542\/peds.105.1.14","volume":"105","author":"MC Walsh-Sukys","year":"2000","unstructured":"Walsh-Sukys MC, Tyson JE, Wright LL et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 2000;105:14\u201320.","journal-title":"Pediatrics"},{"key":"BFpr2017143_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1053\/j.semperi.2013.11.004","volume":"38","author":"J Nair","year":"2014","unstructured":"Nair J, Lakshminrusimha S . Update on PPHN: mechanisms and treatment. Semin Perinatol 2014;38:78\u201391.","journal-title":"Semin Perinatol"},{"key":"BFpr2017143_CR3","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3109\/14767058.2015.1060213","volume":"29","author":"N Nakwan","year":"2016","unstructured":"Nakwan N, Pithaklimnuwong S . Acute kidney injury and pneumothorax are risk factors for mortality in persistent pulmonary hypertension of the newborn in Thai neonates. J Matern Fetal Neonatal Med 2016;29:1741\u20136.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"BFpr2017143_CR4","first-page":"H1921","volume":"259","author":"SH Abman","year":"1990","unstructured":"Abman SH, Chatfield BA, Hall SL, McMurtry IF . Role of endothelium derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990;259:H1921\u20137.","journal-title":"Am J Physiol"},{"key":"BFpr2017143_CR5","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1172\/JCI117281","volume":"93","author":"JR Fineman","year":"1994","unstructured":"Fineman JR, Wong J, Morin FC III, Wild LM, Soifer SJ . Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. J Clin Invest 1994;93:2675\u201383.","journal-title":"J Clin Invest"},{"key":"BFpr2017143_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/humu.20813","volume":"30","author":"S Mitchell","year":"2009","unstructured":"Mitchell S, Ellingson C, Coyne T et al. Genetic variation in the urea cycle: a model resource for investigating key candidate genes for common diseases. Hum Mutat 2009;30:56\u201360.","journal-title":"Hum Mutat"},{"key":"BFpr2017143_CR7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U F\u00f6rstermann","year":"2012","unstructured":"F\u00f6rstermann U, Sessa WC . Nitric oxide synthases: regulation and function. Eur Heart J 2012;33:829\u201337.","journal-title":"Eur Heart J"},{"key":"BFpr2017143_CR8","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1056\/NEJM200106143442404","volume":"344","author":"DL Pearson","year":"2001","unstructured":"Pearson DL, Dawling S, Walsh WF et al. Neonatal pulmonary hypertension\u2013urea cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med 2001;344:1832\u20138.","journal-title":"N Engl J Med"},{"key":"BFpr2017143_CR9","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.1111\/apa.12717","volume":"103","author":"JK Trittmann","year":"2014","unstructured":"Trittmann JK, Nelin LD, Zmuda EJ et al. Arginase I gene single-nucleotide polymorphism is associated with decreased risk of pulmonary hypertension in bronchopulmonary dysplasia. Acta Paediatr 2014;103:e439\u201343.","journal-title":"Acta Paediatr"},{"key":"BFpr2017143_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000244091","volume":"66","author":"RJ Vosatka","year":"1994","unstructured":"Vosatka RJ, Kashyap S, Trifiletti RR . Arginine deficiency accompanies persistent pulmonary hypertension of the newborn. Biol Neonate 1994;66:65\u201370.","journal-title":"Biol Neonate"},{"key":"BFpr2017143_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559\u201375.","journal-title":"Am J Hum Genet"},{"key":"BFpr2017143_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1442-200X.2008.02664.x","volume":"51","author":"S Hosono","year":"2009","unstructured":"Hosono S, Ohno T, Kimoto H et al. Developmental outcomes in persistent pulmonary hypertension treated with nitric oxide therapy. Pediatr Int 2009;51:79\u201383.","journal-title":"Pediatr Int"},{"key":"BFpr2017143_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/jp.2009.139","volume":"30","author":"AA Rosenberg","year":"2010","unstructured":"Rosenberg AA, Lee NR, Vaver KN et al. School-age outcomes of newborns treated for persistent pulmonary hypertension. J Perinatol 2010;30:127\u201334.","journal-title":"J Perinatol"},{"key":"BFpr2017143_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/sj.jp.7210908","volume":"23","author":"RH Clark","year":"2003","unstructured":"Clark RH, Huckaby JL, Kueser TJ et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. J Perinatol 2003;23:300\u20133.","journal-title":"J Perinatol"},{"key":"BFpr2017143_CR15","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1542\/peds.2006-3037","volume":"120","author":"S Hern\u00e1ndez-D\u00edaz","year":"2007","unstructured":"Hern\u00e1ndez-D\u00edaz S, Van Marter LJ, Werler MM et al. Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics 2007;120:e272\u201382.","journal-title":"Pediatrics"},{"key":"BFpr2017143_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/pr.2011.24","volume":"71","author":"HM Byers","year":"2012","unstructured":"Byers HM, Dagle JM, Klein JM et al. Variations in CRHR1 areassociated with persistent pulmonary hypertension of the newborn. Pediatr Res 2012;71:162\u20137.","journal-title":"Pediatr Res"},{"key":"BFpr2017143_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ymgme.2014.01.001","volume":"111","author":"M Catteruccia","year":"2014","unstructured":"Catteruccia M, Verrigni D, Martinelli D et al. Persistent pulmonary arterial hypertension in the newborn (PPHN): a frequent manifestation of TMEM70 defective patients. Mol Genet Metab 2014;111:353\u20139.","journal-title":"Mol Genet Metab"},{"key":"BFpr2017143_CR18","first-page":"179","volume":"20","author":"JM Vonk","year":"2010","unstructured":"Vonk JM, Postma DS, Maarsingh H et al. Arginase 1 and arginase 2 variations associate with asthma, asthma severity and beta2 agonist and steroid response. Genomics 2010;20:179\u201386.","journal-title":"Genomics"},{"key":"BFpr2017143_CR19","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1164\/rccm.200709-1363OC","volume":"178","author":"AA Litonjua","year":"2008","unstructured":"Litonjua AA, Lasky-Su J, Schneiter K et al. ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am J Respir Crit Care Med 2008;178:688\u201394.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFpr2017143_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/jmg.2006.047449","volume":"44","author":"J Dumont","year":"2007","unstructured":"Dumont J, Zureik M, Cottel D et al. Association of arginase 1 gene polymorphisms with the risk of myocardial infarction and common carotid intima media thickness. J Med Genet. 2007;44:526\u201331.","journal-title":"J Med Genet."},{"key":"BFpr2017143_CR21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/ajh.2009.110","volume":"22","author":"J Dumont","year":"2009","unstructured":"Dumont J, Meroufel D, Bauters C et al. Association of ornithine transcarbamylase gene polymorphisms with hypertension and coronary artery vasomotion. Am J Hypertens 2009;22:993\u20131000.","journal-title":"Am J Hypertens"},{"key":"BFpr2017143_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.mito.2006.11.001","volume":"7","author":"JA Canter","year":"2007","unstructured":"Canter JA, Summar ML, Smith HB et al. Genetic variation in the mitochondrial enzyme carbamyl-phosphate synthetase I predisposes children to increased pulmonary artery pressure following surgical repair of congenital heart defects: a validated genetic association study. Mitochondrion 2007;7:204\u201310.","journal-title":"Mitochondrion"},{"key":"BFpr2017143_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/sj.bmt.1704943","volume":"35","author":"AR Kallianpur","year":"2005","unstructured":"Kallianpur AR, Hall LD, Yadav M et al. The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation. Bone Marrow Transplant 2005;35:1155\u201364.","journal-title":"Bone Marrow Transplant"},{"key":"BFpr2017143_CR24","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.ymgme.2003.11.014","volume":"81","author":"ML Summar","year":"2004","unstructured":"Summar ML, Hall L, Christman B et al. Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase I. Mol Genet Metab 2004;81:S12\u20139.","journal-title":"Mol Genet Metab"},{"key":"BFpr2017143_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0378-1119(03)00528-6","volume":"311","author":"ML Summar","year":"2003","unstructured":"Summar ML, Hall LD, Eeds AM et al. Characterization of genomic structure and polymorphisms in the human carbamyl phosphate synthetase I gene. Gene 2003;311:51\u20137.","journal-title":"Gene"},{"key":"BFpr2017143_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0003-9861(92)90431-U","volume":"298","author":"H Ischiropoulos","year":"1992","unstructured":"Ischiropoulos H, Zhu L, Chen J et al. Peroxynitrite mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992;298:431\u20137.","journal-title":"Arch Biochem Biophys"},{"key":"BFpr2017143_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0014-5793(97)00469-9","volume":"411","author":"B Halliwell","year":"1997","unstructured":"Halliwell B . What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 1997;411:157\u201360.","journal-title":"FEBS Lett"},{"key":"BFpr2017143_CR28","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1542\/peds.101.5.870","volume":"101","author":"BA Banks","year":"1998","unstructured":"Banks BA, Ischiropoulos H, McClelland M et al. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics 1998;101:870\u20134.","journal-title":"Pediatrics"},{"key":"BFpr2017143_CR29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/pr.2013.43","volume":"73","author":"KK Ryckman","year":"2013","unstructured":"Ryckman KK, Dagle JM, Shchelochkov OA et al. Association of amino acids with common complications of prematurity. Pediatr Res 2013;73:700\u20135.","journal-title":"Pediatr Res"},{"key":"BFpr2017143_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00726-007-0625-x","volume":"35","author":"M Ploder","year":"2008","unstructured":"Ploder M, Neurauter G, Spittler A et al. Serum phenylalanine in patients post trauma and with sepsis correlate to neopterin concentrations. Amino Acids 2008;35:303\u20137.","journal-title":"Amino Acids"},{"key":"BFpr2017143_CR31","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1161\/01.CIR.0000162470.26840.89","volume":"111","author":"JP Khoo","year":"2005","unstructured":"Khoo JP, Zhao L, Alp NJ et al. Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension. Circulation 2005;111:2126\u201333.","journal-title":"Circulation"},{"key":"BFpr2017143_CR32","doi-asserted-by":"publisher","first-page":"L979","DOI":"10.1152\/ajplung.90238.2008","volume":"295","author":"KN Farrow","year":"2008","unstructured":"Farrow KN, Lakshminrusimha S, Reda WJ et al. Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2008;295:L979\u201387.","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2017143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2017143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/pr.2017.143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/pr2017143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:45Z","timestamp":1684616565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2017143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFpr2017143"],"URL":"https:\/\/doi.org\/10.1038\/pr.2017.143","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,4]]},"assertion":[{"value":"17 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}